Screener
ANI Pharmaceuticals ANIP Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
| (in thousands) | June 30, 2026 / Gross Carrying Amount | June 30, 2026 / Accumulated Amortization | June 30, 2026 / Net Carrying Amount | December 31, 2025 / Gross Carrying Amount | December 31, 2025 / Accumulated Amortization | December 31, 2025 / Net Carrying Amount | Remaining Weighted Average Amortization Period (1) |
|---|---|---|---|---|---|---|---|
| Definite-Lived Intangible Assets: | |||||||
| Acquired ANDAs intangible assets | $214,417 | $(158,199) | $56,218 | $214,260 | $(147,511) | $66,749 | 3.3 years |
| NDAs and product rights | 679,804 | (294,946) | 384,858 | 673,554 | (271,818) | 401,736 | 9.8 years |
| Marketing and distribution rights | 17,157 | (16,676) | 481 | 17,157 | (16,195) | 962 | 0.5 years |
| Customer relationships | 24,900 | (16,600) | 8,300 | 24,900 | (14,821) | 10,079 | 2.3 years |
| Total Intangible Assets, net | $936,278 | $(486,421) | $449,857 | $929,871 | $(450,345) | $479,526 | 8.8 years |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's intangibles (net)?
- ANI Pharmaceuticals (ANIP) reported intangibles (net) of $449.86M in Q2 2026.
- How has ANI Pharmaceuticals's intangibles (net) changed year-over-year?
- ANI Pharmaceuticals's intangibles (net) decreased by 13.5% year-over-year, from $520.32M to $449.86M.
- What is the long-term trend for ANI Pharmaceuticals's intangibles (net)?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's intangibles (net) has grown at a 20.5% compound annual growth rate (CAGR), from $188.51M to $479.53M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about ANI Pharmaceuticals's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude